The European Commission has granted approval to Revlimid (lenalidomide) for the treatment of patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are failing.
The debate over a pharmacy law that forces patients away from GPs who dispense pharmaceuticals is heating up in the House of Lords with a series of questions from five peers to Earl Howe, England’s pharmacy minister.
Nutricia, a division of Danone, has just launched Souvenaid for people who are in the early stages of Alzheimer’s Disease. Souvenaid is a ‘Food for Special Medical Purposes’ that is loaded with the nutrients needed to maintain healthy synapses.
In final guidance published today (25 July), NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for treating deep vein thrombosis and preventing recurrent deep vein thrombosis and pulmonary embolism in adults diagnosed with acute deep vein thrombosis (DVT).